1615.1000 -17.00 (-1.04%)
NSE Aug 06, 2025 11:11 AM
Volume: 791.8K
 

1615.10
-1.04%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 16.4% YoY to | 7224.2 crore (I-direct estimate: | 7131.4 crore) mainly due to 22% growth in India formulation to | 2152 crore (I-direct estimate: | 2130.5 crore) led by lower base of GST impact in Q1FY18. US sales grew 12.3% YoY to | 2542.2 crore (I-direct estimate: | 2543 crore). Taro's sales remained flat at | 1034.4 crore (I-direct estimate: | 1208.7 crore) EBITDA margins improved 459 bps to 22.2% (I-direct estimate of...
Geojit BNP Paribas upgraded Sun Pharmaceutical Industries Ltd. to Buy with a price target of 1830.0 on 05 Aug, 2025.
More from Sun Pharmaceutical Industries Ltd.
Recommended